Stock Scorecard
Stock Summary for Abbvie Inc (ABBV) - $215.20 as of 5/22/2026 7:00:12 PM EST
Total Score
7 out of 30
Safety Score
52 out of 100
Currently on the following lists
None
Tim's Recommendation
Avoid
Growth List Algorithm Criteria for ABBV
| Positive Quarterly and Annual earnings growth | |
| P/E ratio less than Industry P/E Ratio | |
| P/E ratio less than Sector P/E Ratio | |
| P/E ratio that is half the Annual earnings growth rate (or less) | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Positive net income past year and 12 trailing months | |
| Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for ABBV
| Revenue growing by at least 20% average per year over the last 5 years | |
| Market Capitalization under 2 billion | |
| Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
| Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
| Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for ABBV
| Declared an ex-dividend date | |
| Forward annual dividend rate greater than 2 | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Current ratio most recent quarter greater than 2 | |
| Cash Flow per Share greater than Trailing Dividend Rate |
Bonus Criteria for ABBV
| P/E ratio less than five-year Average P/E ratio | |
| Last Price to 52 Week Low Ratio Less Than 1 | |
| Total Cash Per Share > Last Day Price | |
| P/S Ratio < 1 | |
| P/B Ratio < 1 |
Safety Rating Criteria for ABBV (52 out of 100)
| Stock Price Rating (Max of 10) | 10 |
| Historical Stock Price Rating (Max of 10) | 10 |
| Stock Price Trend (Max of 10) | 9 |
| Book Value (Max of 10) | 1 |
| Book Value to Price (Max of 10) | 0 |
| Analyst Buy Ratings (Max of 5) | 5 |
| Analyst Strong Buy Ratings (Max of 5) | 5 |
| Dividend Yield Percentage (Max of 10) | 6 |
| Operating Margin (Max of 10) | 6 |
| Trading Volume (Max of 10) | 10 |
| Price to Earnings (Max of 10) | 0 |
| Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) | -10 |
Latest News for for ABBV
Financial Details for ABBV
Company Overview |
|
|---|---|
| Ticker | ABBV |
| Company Name | Abbvie Inc |
| Country | N/A |
| Description | AbbVie is an American publicly traded biopharmaceutical company founded in 2013. It originated as a spin-off of Abbott Laboratories. |
| Sector Name | HEALTHCARE |
| Industry Name | DRUG MANUFACTURERS - GENERAL |
| Most Recent Quarter | 3/31/2026 |
| Next Earnings Date | N/A |
Stock Price History |
|
| Last Day Price | 215.20 |
| Price 4 Years Ago | 142.34 |
| Last Day Price Updated | 5/22/2026 7:00:12 PM EST |
| Last Day Volume | 3,814,054 |
| Average Daily Volume | 6,433,452 |
| 52-Week High | 239.13 |
| 52-Week Low | 174.56 |
| Last Price to 52 Week Low | 23.28% |
Valuation Measures |
|
| Trailing PE | N/A |
| Industry PE | 22.38 |
| Sector PE | 73.16 |
| 5-Year Average PE | 28.72 |
| Free Cash Flow Ratio | 40.45 |
| Industry Free Cash Flow Ratio | 40.48 |
| Sector Free Cash Flow Ratio | 29.12 |
| Current Ratio Most Recent Quarter | 0.80 |
| Total Cash Per Share | 5.32 |
| Book Value Per Share Most Recent Quarter | -3.77 |
| Price to Book Ratio | 50.46 |
| Industry Price to Book Ratio | 9.44 |
| Sector Price to Book Ratio | 18.99 |
| Price to Sales Ratio Twelve Trailing Months | 6.01 |
| Industry Price to Sales Ratio Twelve Trailing Months | 4.48 |
| Sector Price to Sales Ratio Twelve Trailing Months | 8.52 |
| Analyst Buy Ratings | 16 |
| Analyst Strong Buy Ratings | 8 |
Share Statistics |
|
| Total Shares Outstanding | 1,766,793,000 |
| Market Capitalization | 380,213,853,600 |
| Institutional Ownership | N/A |
Dividends |
|
| Ex-Dividend Date | 4/15/2026 |
| Previous Dividend Amount | 1.7300 |
| Current Dividend Amount | 1.7300 |
| Total Years Dividend Increasing |
|
| Trailing Annual Dividend Rate | 6.74 |
| Trailing Annual Dividend Yield | 3.13% |
| Forward Annual Dividend Rate | 6.92 |
| Forward Annual Dividend Yield | 3.22% |
| 5-Year Dividend Payments Count | 20 |
| 3-Year Average Dividend Yield | 2.92% |
| 5-Year Average Dividend Yield | 3.68% |
| 1-Year Dividend Growth Rate Percentage | 5.49% |
| 3-Year Dividend Growth Rate Percentage | 2.71% |
| 5-Year Dividend Growth Rate Percentage | 5.25% |
| All-Time Dividend Growth Rate Percentage | 12.48% |
| Dividend Payout Ratio | 332.02% |
Income Statement |
|
| Quarterly Earnings Growth YOY | -46.20% |
| Annual Earnings Growth | -1.22% |
| Reported EPS 12 Trailing Months | 2.03 |
| Reported EPS Past Year | 2.65 |
| Reported EPS Prior Year | 10.00 |
| Net Income Twelve Trailing Months | 3,639,000,000 |
| Net Income Past Year | 4,226,000,000 |
| Net Income Prior Year | 4,278,000,000 |
| Quarterly Revenue Growth YOY | 12.40% |
| 5-Year Revenue Growth | 5.95% |
| Operating Margin Twelve Trailing Months | 32.20% |
Balance Sheet |
|
| Total Cash Most Recent Quarter | 9,391,000,000 |
| Total Cash Past Year | 5,229,000,000 |
| Total Cash Prior Year | 5,524,000,000 |
| Net Cash Position Most Recent Quarter | -55,141,000,000 |
| Net Cash Position Past Year | -53,712,000,000 |
| Long Term Debt Past Year | 58,941,000,000 |
| Long Term Debt Prior Year | 60,340,000,000 |
| Total Debt Most Recent Quarter | 64,532,000,000 |
| Equity to Debt Ratio Past Year | -0.06 |
| Equity to Debt Ratio Most Recent Quarter | 0.30 |
| Total Stockholder Equity Past Year | -3,270,000,000 |
| Total Stockholder Equity Prior Year | 3,325,000,000 |
| Total Stockholder Equity Most Recent Quarter | 27,499,000,000 |
Free Cash Flow |
|
| Free Cash Flow Twelve Trailing Months | 19,857,000,000 |
| Free Cash Flow Per Share Twelve Trailing Months | 11.24 |
| Free Cash Flow Past Year | 17,816,000,000 |
| Free Cash Flow Prior Year | 17,832,000,000 |
Options |
|
| Put/Call Ratio | 0.59 |
| Has Options | Options Chain |
| Liquidity Rating | |
Technical Analysis |
|
| Yahoo Finance Chart | Yahoo Finance Chart |
| MACD | 0.91 |
| MACD Signal | -0.35 |
| 20-Day Bollinger Lower Band | 195.68 |
| 20-Day Bollinger Middle Band | 214.02 |
| 20-Day Bollinger Upper Band | 232.37 |
| Beta | 0.30 |
| RSI | 57.40 |
| 50-Day SMA | 210.37 |
| 150-Day SMA | 177.52 |
| 200-Day SMA | 166.06 |
System |
|
| Modified | 5/22/2026 4:17:37 PM EST |